Recent Articles

• Columbus A/S Share Buyback Update and Overview
• Cognizant Partners with AP Pension for Strategic Growth
• Impact of Federal EV Subsidy Changes on Tesla and Investors
• Broadcom's Promising Future: Growth Powered by AI Partnerships
• Investigation of PubMatic and Class Action Suit Options
• Nutex Health Inc.: Investors' Chance to Join Potential Class Action
• Seeking Justice: Fly-E Group, Inc. Investors Unite for Class Action
• Tronox Holdings Faces Lawsuit: An Investor's Perspective
• Nobel Laureate Inspires at Sustainable Global Leaders Gathering
• Municipality Finance Expands Offerings with New EUR 50M Bond Tap
• NORBIT Secures Significant NOK 120M Defence Order
• CMB.TECH Achieves Fleet Expansion and Revenue Growth
• CMB.TECH NV Initiates Fixed Income Investor Engagements
• JSBC Launches Books Showcasing Chinese Culture and Wisdom
• dsb.net UK Expands Leadership Team to Boost Growth Strategy
• Exciting Halloween Update for My Talking Tom Friends Revealed
• Understanding Foster Care Through the Lens of Resilience
• Cognizant to Empower AP Pension with Innovative Solutions
• CHINT Electric: Pioneering Efficient Solutions for Industry
• Discover Medela's Motion InBra™: Revolutionizing Breast Pumping
• Municipality Finance Strengthens Position With New SEK 1B Note
• Aspocomp's Upcoming Interim Report Highlights Growth Potential
• CMB.TECH Continues Fleet Revitalization Amid Market Fluctuations
• CMB.TECH NV: Series of Fixed Income Investor Meetings Announced
• Chery Unveils Transformable Multi-SUV at Global Brand Night
• Transgene and BioInvent's BT-001 Demonstrates Progress in Cancer Therapy
• AlphaMedix Data Shows Promising Results for Rare Cancer Treatment
• Soitec and CEA Innovate Advancements in Automotive Cybersecurity
• Celebrating Cultural Heritage: Highlights from the Liangzhu Forum
• Breakthrough in Urothelial Carcinoma Treatment at ESMO Congress 2025
• Investa Expands Horizons with New Crowdcube Fundraising Venture
• IO Biotech Unveils Phase 3 Findings on Cylembio and KEYTRUDA
• AlphaMedix Phase 2 Study Highlights Transformative Potential
• AlphaMedix Phase 2 Study Reveals Hope for GEP-NET Treatment
• BT-001 Shows Promise in Advanced Solid Tumors Alongside Therapy
• Innovative Solutions in Automotive Cybersecurity via FD-SOI
• Key Insights on Debtor Distribution Data for Investors
• Nykredit Realkredit A/S Publishes Important Debtor Data
• Recent Progress in US-South Korea Tariff Negotiations Explained
• Understanding Nvidia's Energy Challenge Amid AI Advancements
• Navigating the Class Action for MoonLake Immunotherapeutics
• Investors Encouraged to Join Lawsuit Against Quanex Building Products
• Liquid Wind Marks Major Milestone for eFuel Production Facility
• Chung Kisun Elevated to Chairman of HD Hyundai Leadership
• Nordic Fusion Energy Development: Future Prospects and Locations
• EXEED's Texxeract Technology Unveiled with New Model Designs
• Effective Immunotherapy Approaches for Aggressive Skin Cancer
• VAALCO Energy Announces Upcoming Earnings Conference Details
• MILESEEY Golf’s Innovative GenePro G1 Rangefinder Shines Bright
• Chery's Ride Green Life: A Step Towards Global Sustainability